Literature DB >> 18363205

Cancer Vaccines 2007. Cancer and HIV Vaccines: Shared Lessons. October 4-6, 2007, New York, USA. Abstracts.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18363205      PMCID： PMC2935788     

Source DB:  PubMed          Journal:  Cancer Immun        ISSN： 1424-9634


× No keyword cloud information.
  20 in total

1.  Ex vivo detectable activation of Melan-A-specific T cells correlating with inflammatory skin reactions in melanoma patients vaccinated with peptides in IFA.

Authors:  Danielle Liénard; Donata Rimoldi; Marie Marchand; Pierre-Yves Dietrich; Nicolas van Baren; Christine Geldhof; Pascal Batard; Philippe Guillaume; Maha Ayyoub; Mikaël J Pittet; Alfred Zippelius; Katharina Fleischhauer; Ferdy Lejeune; Jean-Charles Cerottini; Pedro Romero; Daniel E Speiser
Journal:  Cancer Immun       Date:  2004-05-19

2.  Striking immunodominance hierarchy of naturally occurring CD8+ and CD4+ T cell responses to tumor antigen NY-ESO-1.

Authors:  Heather Jackson; Nektaria Dimopoulos; Nicole A Mifsud; Tsin Yee Tai; Qiyuan Chen; Suzanne Svobodova; Judy Browning; Immanuel Luescher; Lisa Stockert; Lloyd J Old; Ian D Davis; Jonathan Cebon; Weisan Chen
Journal:  J Immunol       Date:  2006-05-15       Impact factor: 5.422

Review 3.  Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses.

Authors:  Jonathan W Yewdell
Journal:  Immunity       Date:  2006-10       Impact factor: 31.745

4.  A novel approach to characterize clonality and differentiation of human melanoma-specific T cell responses: spontaneous priming and efficient boosting by vaccination.

Authors:  Daniel E Speiser; Petra Baumgaertner; Catherine Barbey; Verena Rubio-Godoy; Alexandre Moulin; Patricia Corthesy; Estelle Devevre; Pierre-Yves Dietrich; Donata Rimoldi; Danielle Liénard; Jean-Charles Cerottini; Pedro Romero; Nathalie Rufer
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

5.  New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site.

Authors:  Victor Appay; Camilla Jandus; Verena Voelter; Severine Reynard; Sarah E Coupland; Donata Rimoldi; Danielle Lienard; Philippe Guillaume; Arthur M Krieg; Jean-Charles Cerottini; Pedro Romero; Serge Leyvraz; Nathalie Rufer; Daniel E Speiser
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

6.  Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides.

Authors:  Sander Zwaveling; Sandra C Ferreira Mota; Jan Nouta; Mark Johnson; Grayson B Lipford; Rienk Offringa; Sjoerd H van der Burg; Cornelis J M Melief
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

7.  The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells.

Authors:  Lisa M Ebert; Bee Shin Tan; Judy Browning; Suzanne Svobodova; Sarah E Russell; Naomi Kirkpatrick; Craig Gedye; Denis Moss; Sweet Ping Ng; Duncan MacGregor; Ian D Davis; Jonathan Cebon; Weisan Chen
Journal:  Cancer Res       Date:  2008-04-15       Impact factor: 12.701

8.  Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming.

Authors:  Danila Valmori; Naira E Souleimanian; Valeria Tosello; Nina Bhardwaj; Sylvia Adams; David O'Neill; Anna Pavlick; Juliet B Escalon; Crystal M Cruz; Angelica Angiulli; Francesca Angiulli; Gregory Mears; Susan M Vogel; Linda Pan; Achim A Jungbluth; Eric W Hoffmann; Ralph Venhaus; Gerd Ritter; Lloyd J Old; Maha Ayyoub
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-15       Impact factor: 11.205

9.  Unmodified self antigen triggers human CD8 T cells with stronger tumor reactivity than altered antigen.

Authors:  Daniel E Speiser; Petra Baumgaertner; Verena Voelter; Estelle Devevre; Catherine Barbey; Nathalie Rufer; Pedro Romero
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-04       Impact factor: 11.205

10.  HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1.

Authors:  Marcus Altfeld; Elizabeth T Kalife; Ying Qi; Hendrik Streeck; Mathias Lichterfeld; Mary N Johnston; Nicole Burgett; Martha E Swartz; Amy Yang; Galit Alter; Xu G Yu; Angela Meier; Juergen K Rockstroh; Todd M Allen; Heiko Jessen; Eric S Rosenberg; Mary Carrington; Bruce D Walker
Journal:  PLoS Med       Date:  2006-10       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.